- Home
- CNTA vs STAA Comparison
CNTA vs STAA Comparison
Compare CNTA & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | STAA |
|---|---|---|
| Founded | 2020 | 1982 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 1.2B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTA | STAA |
|---|---|---|
| Price | $25.33 | $23.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 10 |
| Target Price | ★ $37.70 | $24.56 |
| AVG Volume (30 Days) | 1.3M | ★ 1.5M |
| Earning Date | 11-05-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $15,000,000.00 | ★ $230,591,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $21.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 118.88 | N/A |
| 52 Week Low | $9.60 | $13.50 |
| 52 Week High | $30.58 | $30.81 |
Technical Indicators
Market Signals| Indicator | CNTA | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 42.85 | 41.85 |
| Support Level | $24.17 | $22.90 |
| Resistance Level | $26.01 | $26.18 |
| Average True Range (ATR) | 1.20 | 1.46 |
| MACD | -0.37 | -0.11 |
| Stochastic Oscillator | 19.03 | 8.86 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.